NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Down 93.3% in April

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totalling 100 shares, a decrease of 93.3% from the March 31st total of 1,500 shares. Based on an average daily volume of 7,700 shares, the short-interest ratio is currently 0.0 days.

NLS Pharmaceutics Price Performance

Shares of NASDAQ NLSPW remained flat at $0.03 during mid-day trading on Thursday. The stock had a trading volume of 1,000 shares, compared to its average volume of 14,097. NLS Pharmaceutics has a 12 month low of $0.01 and a 12 month high of $0.18. The company has a 50 day moving average price of $0.05 and a 200-day moving average price of $0.07.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).